Effect of serum vitamin D on metabolic associated fatty liver disease: a large population-based study

References

• Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686–690.
   PubMed Web of Science ®Google Scholar
• YounossiZobair M, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;1:73–84.
   Google Scholar
• Younossi Z, Anstee Q, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20.
   PubMed Web of Science ®Google Scholar
• Rinella M. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–2273.
   PubMed Web of Science ®Google Scholar
• Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis. 2009;13(4):545–563.
   PubMed Web of Science ®Google Scholar
• Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007;133(2):496–506.
   PubMed Web of Science ®Google Scholar
• Mohammed E, Arun JS, Jacob G, et al. AFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.
   PubMed Web of Science ®Google Scholar
• Valenti L, Pelusi S. Redefining fatty liver disease classification in 2020. Liver Int. 2020;40(5):1016–1017.
   PubMed Web of Science ®Google Scholar
• Fouad Y, Waked I, Bollipo S, et al. What's in a name? Renaming 'NAFLD' to 'MAFLD'. Liver Int. 2020;40(6):1254–1261.
   PubMed Web of Science ®Google Scholar
• Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int. 2020;40(9):2082–2089.
   PubMed Web of Science ®Google Scholar
• Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroen Hepatol. 2002; 17(Suppl 1):S186–S90.
   PubMed Web of Science ®Google Scholar
• Barchetta I, Cimini FA, Cavallo MG. Vitamin D supplementation and non-alcoholic fatty liver disease: present and future. Nutrients. 2017;9(9):1015.
   PubMed Web of Science ®Google Scholar
• Kupferschmidt K. Uncertain verdict as vitamin D goes on trial. Science. 2012;337(6101):1476–1478.
   PubMed Web of Science ®Google Scholar
• Hewison M. An update on vitamin D and human immunity. Clin Endocrinol. 2012;76(3):315–325.
   PubMed Web of Science ®Google Scholar
• Wagner CLG, Frank R. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;5:1142–1152.
   Web of Science ®Google Scholar
• Gagnon C, Lu ZX, Magliano DJ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study. J Clin Endocrinol Metab. 2012;97(6):1953–1961.
   PubMed Web of Science ®Google Scholar
• Chen L-W, Chien C-Y, Hsieh C-W, et al. The associations between helicobacter pylori infection, serum vitamin D, and metabolic syndrome a community-based study. Medicine. 2016;95(18):e3616.
   PubMed Web of Science ®Google Scholar
• Targher G, Targher CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341–1350.
   PubMed Web of Science ®Google Scholar
• Theodoratou E, Tzoulaki I, Zgaga L, et al. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and Meta-analyses of observational studies and randomised trials. BMJ. 2014;348(apr01 2):g2035–g2035.
   PubMed Web of Science ®Google Scholar
• Holick MF. Medical progress: vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.
   PubMed Web of Science ®Google Scholar
• Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252–261.
   PubMed Web of Science ®Google Scholar
• Bradlee ML, Singer MR, Qureshi MM, Moore LL. Food group intake and Central obesity among children and adolescents in the third national health and nutrition examination survey (NHANES III). Public Health Nutr. 2010;13(6):797–805.
   PubMed Web of Science ®Google Scholar
• Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Food Nutr Bull. 2014;39(4):322–350.
   Google Scholar
• Smotkin-Tangorra M, Purushothaman R, Gupta A, et al. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab. 2007;20(7):817–823.
   PubMed Web of Science ®Google Scholar
• Almoudi MM, Hussein AS, Abu HMI, et al. Dental caries and vitamin D status in children in Asia. Pediatr Int. 2019;61(4):327–338.
   PubMed Web of Science ®Google Scholar
• Liu L, Cao Z, Lu F, et al. Vitamin D deficiency and metabolic syndrome in elderly Chinese individuals: evidence from CLHLS. Nutr Metab. 2020;17(1):58.
   Google Scholar
• Cheng Q, Du Y, Hong W, et al. Factors associated to serum 25-hydroxyvitamin D levels among older adult populations in urban and suburban communities in shanghai, China. BMC Geriatr. 2017;17(1):246.
   PubMed Web of Science ®Google Scholar
• Van BS, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;3:1–67.
   Google Scholar
• Vandenbroucke JP, Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (strobe): explanation and elaboration. Ann Intern Med. 2007;147(8):W–94.
   Web of Science ®Google Scholar
• Chen L-W, Chien C-H, Kuo S-F, et al. Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. BMC Gastroenterol. 2019;19(1):1–8.
   PubMed Web of Science ®Google Scholar
• Bril F, Maximos M, Portillo-Sanchez P, et al. Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol. 2015;62(2):405–411.
   PubMed Web of Science ®Google Scholar
• Liu X-J, Wang B-W, Zhang C, et al. Vitamin D deficiency attenuates high-fat diet-induced hyperinsulinemia and hepatic lipid accumulation in male mice. Endocrinology. 2015;156(6):2103–2113.
   PubMed Web of Science ®Google Scholar
• Liu S, Wang M, Zhang N, et al. Association between vitamin D status and non-alcoholic fatty liver disease: a population-based study. J Nutr Sci Vitaminol. 2019;65(4):303–308.
   PubMed Web of Science ®Google Scholar
• Lee I, Park E, Cho J. Association of nonalcoholic fatty liver disease with serum vitamin D levels in combination of physical fitness in Korean older adults. J Steroid Biochem Mol Biol. 2020;198:105569.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
   PubMed Web of Science ®Google Scholar
• Dietary reference intakes for calcium and vitamin D. Pediatrics. 2012;130(5):e1424.
   Google Scholar
• Hagenau T, Vest R, Gissel TN, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2009;20(1):133–140.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–2029.
   PubMed Web of Science ®Google Scholar
• Chiu KC, Chu A, Go VLW, et al. Hypovitaminosis D is associated with insulin resistance ß cell dysfunction. Am J Clin Nutr. 2004;5:820–825.
   Google Scholar
• Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28(5):1228–1230.
   PubMed Web of Science ®Google Scholar
• Barchetta I, Cimini FA, Cavallo MG. Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update. Nutrients. 2020;12(11):3302.
   PubMed Web of Science ®Google Scholar
• Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–693.
   PubMed Web of Science ®Google Scholar
• Arunabh S, Pollack S, Yeh J, et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88(1):157–161.
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey AB, Ames RW, et al. The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr. 2007;86(4):959–964.
   PubMed Web of Science ®Google Scholar
• Jafari T, Fallah AA, Barani A. Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Clin Nut. 2016;35(6):1259–1268.
   PubMed Web of Science ®Google Scholar
• Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2):491S-499S.
   Google Scholar
• Cheng KH, Huang SP, Huang CN, et al. The impact of estradiol and 1,25(OH)2D3 on metabolic syndrome in middle-aged Taiwanese males. PLoS One. 2013;8(3):e60295.
   PubMed Web of Science ®Google Scholar
• Barchetta I, Angelico F, Ben MD, et al. Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9(1):85.
   PubMed Web of Science ®Google Scholar
• Giulietti A, Ev E, Overbergh L, et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1,25-dihydroxyvitamin D3 works as anti-inflammatory. Diabetes Res Clin Pr. 2008;1:47–57.
   Google Scholar
• Khoo A-L, Chai LYA, Koenen HJPM, et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol. 2011;1:72–79.
   Web of Science ®Google Scholar
• Kazankov K, Jørgensen SMD, Thomsen KL, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145–159.
   PubMed Web of Science ®Google Scholar
• Roth CL, Elfers CT, Figlewicz DP, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation. Hepatology. 2012;55(4):1103–1111.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovas. 2007;17(7):517–524.
   Web of Science ®Google Scholar
• Ra A, Hastier A, Canivet CM, et al. Severe vitamin D deficiency is not associated with liver damage in morbidly obese patients. Obes Surg. 2016;9:2138–2143.
   Google Scholar
• Eddowes PJ, Sasso M, Allison M, et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–1730.
   PubMed Web of Science ®Google Scholar
• Mikolasevic I, Lukenda ZV, Jakopcic I, et al. Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. J Diabetes Complicat. 2020;34(3):107512.
   PubMed Web of Science ®Google Scholar
• Zhou J-H, Cai J-J, She Z-G, et al. Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice. World J Gastroenterol. 2019;25(11):1307–1326.
   PubMed Web of Science ®Google Scholar